Ruoqian Cheng

399 Wanyuan Road
Shanghai, 201102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Long-Acting PEGylated Growth Hormone in Children with Idiopathic Short Stature: 2-Year Results.

Long-Acting PEGylated Growth Hormone in Children with Idiopathic Short Stature: 2-Year Results.

Journal: Hormone research in paediatrics

Published: October 30, 2025

A Child with Cutaneous-Skeletal Hypophosphatemia Syndrome Caused by a Mosaic HRAS Mutation: Outcome of Treatment with Anti-FGF23 Antibody.

A Child with Cutaneous-Skeletal Hypophosphatemia Syndrome Caused by a Mosaic HRAS Mutation: Outcome of Treatment with Anti-FGF23 Antibody.

Journal: Calcified tissue international

Published: January 07, 2025

Genome-wide Mendelian randomization identifies drugs associated with body height.

Genome-wide Mendelian randomization identifies drugs associated with body height.

Journal: Translational pediatrics

Published: July 09, 2024

Factors affecting growth hormone treatment in short stature children born small for gestational age in China: a single-centre, real-world study.

Factors affecting growth hormone treatment in short stature children born small for gestational age in China: a single-centre, real-world study.

Journal: Endocrine

Published: April 01, 2024

Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.

Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.

Journal: BMC pediatrics

Published: August 11, 2023

Long-acting PEGylated growth hormone in children with idiopathic short stature.

Long-acting PEGylated growth hormone in children with idiopathic short stature.

Journal: European journal of endocrinology

Published: May 18, 2022

A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review.

A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review.

Journal: Translational pediatrics

Published: May 12, 2022

Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals.

Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 13, 2022

Corrigendum: Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.

Corrigendum: Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.

Journal: Frontiers in endocrinology

Published: December 07, 2021

Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.

Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.

Journal: Frontiers in endocrinology

Published: September 18, 2021

Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects.

Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 24, 2021

An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children.

An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children.

Journal: Medicine

Published: March 22, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026